PYXS dilution watch: offerings and filings
PYXS (Pyxis Oncology, Inc.) filed a new prospectus supplement (424B) on Thursday, October 1, 2026 (S-3). Below is every offering event for the name in the last 60 days, newest first, and its Momo Meter alert history: 1 alert in 90 days, last Nov 19, 3:59 PM.
Dilution status: Can Dilute Anytime (risk level High, as of Nov 19, 2026).
PYXS's SEC filings: View PYXS's filings on SEC.gov
PYXS registrations
| Form | Status | Registered | At-the-market program | Shelf good until | Latest step | Filing |
|---|---|---|---|---|---|---|
| S-3 333-291801 | Selling now | - | Yes | Dec 9, 2028 | Prospectus supplement Oct 1, 2026 | View the S-3 on SEC.gov |
| S-3 333-298461 | Selling now | $128.6 million | - | Aug 27, 2029 | Prospectus supplement Aug 28, 2026 | View the S-3 on SEC.gov |
| S-3 333-278282 | Cleared by the SEC, can sell later | - | - | Apr 3, 2027 | Cleared by the SEC Apr 3, 2024 | View the S-3 on SEC.gov |
Cash runway
About 8 months of cash at its current burn. Estimated from the company's latest reported cash and quarterly burn (report dated Sep 30, 2026).
PYXS offering events, last 60 days
| Date | Event | Momo Meter alerts, 90 days |
|---|---|---|
| Oct 1, 2026 | New 424B filed a new prospectus supplement (424B), S-3, shelf, at the market View the S-3 on SEC.gov | 1 last Nov 19, 3:59 PM |
| Sep 29, 2026 | Priced priced an offering, S-3, shelf, at the market View the S-3 on SEC.gov | 1 last Nov 19, 3:59 PM |
A registration (S-1 or S-3) is permission to sell new shares later; effective means the SEC cleared it; a pricing or a 424B supplement means shares are being sold now; an MEF adds shares to a sale in progress. New shares sold into the market dilute existing holders.
Short sale restriction and Reg SHO days
PYXS was not on the short sale restriction (SSR) list in the last 60 days of stored lists.
PYXS was not on the Reg SHO threshold list in the last 60 days of stored lists.
PYXS trading halts
PYXS was last halted on Aug 11, 2026. PYXS trading halt history